Natural Self-Assembly of Allergen-S-Layer Fusion Proteins Is No Prerequisite for Reduced Allergenicity and T Cell Stimulatory Capacity

被引:13
作者
Gerstmayr, Marianne
Ilk, Nicola [2 ]
Jahn-Schmid, Beatrice
Sleytr, Uwe B. [2 ]
Bohle, Barbara [1 ]
机构
[1] Med Univ Vienna, Ctr Physiol Pathophysiol & Immunol, Dept Pathophysiol, Christian Doppler Lab Immunomodulat, AT-1090 Vienna, Austria
[2] Univ Nat Resources & Appl Life Sci, Ctr Nanobiotechnol, Vienna, Austria
基金
奥地利科学基金会;
关键词
Allergy; Antigen presentation; Major birch pollen allergen; Recombinant fusion protein; Specific immunotherapy; Vaccines; BIRCH POLLEN ALLERGEN; BET V 1; DENDRITIC CELLS; FOOD ALLERGENS; IN-VITRO; IMMUNOTHERAPY; VACCINATION; EPITOPE; TOOL; REACTIVITY;
D O I
10.1159/000199718
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
Background: Recombinant allergen-S-layer fusion proteins display a strongly reduced IgE-binding activity and promote the induction of allergen-specific Th0/1 cells and regulatory T cells. Such fusion proteins show a natural capacity to self-assemble into mono- or double-layer sheets reaching particle-like dimensions of 0.5-2 mu m. We were interested in finding out whether self-assembly was crucial for the immunological characteristics of allergen-S-layer fusion proteins. Methods: The IgE-binding and mediator-releasing capacities of nonassembled and self-assembled rSbpA-Bet v 1, consisting of the major birch pollen allergen Bet v 1 and the S-layer protein SbpA, were compared in inhibition ELISA and basophil activation assays using sera from patients allergic to birch pollen. T cell stimulation was evaluated using Bet v 1-specific T cell clones reactive to distinct epitopes of Bet v 1. Autologous B lymphocytes, monocytes and monocyte-derived dendritic cells were employed to evaluate potential differences in uptake and processing by different antigenpresenting cells. Results: Both rSbpA-Bet v 1 variants showed significantly less IgE-binding and mediator-releasing activity than Bet v 1. However, self-assembly further minimized the reduced allergenicity of nonassembled rSbpA-Bet v 1. Both rSbpA-Bet v 1 variants induced comparable proliferation in Bet v 1-specific T cell clones. B cells inappropriately presented either variant of rSbpA-Bet v 1. Self-assembly amplified the T cell stimulatory capacity of monocytes and dendritic cells. Conclusions: The promising characteristics of allergen-S-layer fusion proteins regarding their potential use for allergy treatment do not depend on the formation of particle-like structures. Copyright (c) 2009 S. Karger AG, Basel
引用
收藏
页码:231 / 238
页数:8
相关论文
共 37 条
[1]
Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO
[2]
2-C
[3]
Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects [J].
Bellinghausen, I ;
Metz, G ;
Enk, AH ;
Christmann, S ;
Knop, J ;
Saloga, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) :1131-1139
[4]
A novel approach to specific allergy treatment:: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity [J].
Bohle, B ;
Breitwieser, A ;
Zwölfer, B ;
Jahn-Schmid, B ;
Sára, M ;
Sleytr, UB ;
Ebner, C .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6642-6648
[5]
A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination [J].
Bonura, A. ;
Corinti, S. ;
Artale, A. ;
Di Felice, G. ;
Amoroso, S. ;
Melis, M. ;
Geraci, D. ;
Colombo, P. .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 142 (04) :274-284
[6]
BOUSQUET J, 1998, ALLERGY S, V53, P20
[7]
A recombinant bacterial cell surface (S-layer)-major birch pollen allergen-fusion protein (rSbsC/Bet v1) maintains the ability to self-assemble into regularly structured monomolecular lattices and the functionality of the allergen [J].
Breitwieser, A ;
Egelseer, EM ;
Moll, D ;
Ilk, N ;
Hotzy, C ;
Bohle, B ;
Ebner, C ;
Sleytr, UB ;
Sára, M .
PROTEIN ENGINEERING, 2002, 15 (03) :243-249
[8]
Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses [J].
Bublin, Merima ;
Hoflehner, Elisabeth ;
Wagner, Birgit ;
Radauer, Christian ;
Wagner, Stefan ;
Hufnagl, Karin ;
Allwardt, Dorothee ;
Kundi, Michael ;
Scheiner, Otto ;
Wiedermann, Ursula ;
Breiteneder, Heirno .
VACCINE, 2007, 25 (50) :8395-8404
[9]
Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[10]
EBNER C, 1995, J IMMUNOL, V154, P1932